Guardant Health to Report Second Quarter 2024 Financial Results on August 7, 2024
Guardant Health (Nasdaq: GH), a leading precision oncology company, announced it will release its second quarter 2024 financial results on Wednesday, August 7, 2024, after market close.
The company will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET, accessible via a live webcast on the company’s website.
The webcast will be archived and available for replay after the event.
Guardant Health (Nasdaq: GH), un'azienda leader nella oncologia di precisione, ha annunciato che pubblicherà i suoi risultati finanziari del secondo trimestre 2024 mercoledì 7 agosto 2024, dopo la chiusura del mercato.
L'azienda ospiterà una call di conferenza alle 13:30 PT / 16:30 ET, accessibile tramite una diretta web sul sito dell'azienda.
La diretta sarà archiviata e disponibile per la riproduzione dopo l'evento.
Guardant Health (Nasdaq: GH), una empresa líder en oncología de precisión, anunció que publicará sus resultados financieros del segundo trimestre de 2024 el miércoles 7 de agosto de 2024, después del cierre del mercado.
La empresa llevará a cabo una llamada de conferencia a la 1:30 p.m. PT / 4:30 p.m. ET, accesible a través de una transmisión en vivo en el sitio web de la empresa.
La transmisión se archivará y estará disponible para re reproducción después del evento.
가드언트 헬스(나스닥: GH), 선도적인 정밀 온콜로지 기업이 2024년 2분기 재무 결과를 2024년 8월 7일 수요일, 시장이 마감된 후 발표할 것이라고 발표했습니다.
회사는 오후 1시 30분(태평양 표준시) / 오후 4시 30분(동부 표준시)에 컨퍼런스 콜을 진행하며, 회사 웹사이트에서 라이브 웹캐스트를 통해 접근할 수 있습니다.
웹캐스트는 이벤트 후 다시 보기 위해 아카이브되어 제공될 것입니다.
Guardant Health (Nasdaq: GH), une entreprise pionnière en oncologie de précision, a annoncé qu'elle publiera ses résultats financiers du deuxième trimestre 2024 le mercredi 7 août 2024, après la fermeture des marchés.
L'entreprise organisera une conférence téléphonique à 13h30 PT / 16h30 ET, accessible via une diffusion en direct sur le site web de l'entreprise.
La diffusion sera archivées et disponible pour rediffusion après l'événement.
Guardant Health (Nasdaq: GH), ein führendes Unternehmen im Bereich präzise Onkologie, hat angekündigt, dass es seine Finanzergebnisse für das zweite Quartal 2024 am Mittwoch, den 7. August 2024, nach Marktende veröffentlichen wird.
Das Unternehmen wird um 13:30 Uhr PT / 16:30 Uhr ET eine Telefonkonferenz veranstalten, die über ein Live-Webcast auf der Unternehmenswebsite zugänglich ist.
Der Webcast wird archiviert und nach der Veranstaltung zur Wiederholung verfügbar sein.
- Announcement of second quarter 2024 financial results date provides investors with a timeline for important financial disclosures.
- None.
Live audio of the webcast will be available on the “Investors” section of the company website at: www.guardanthealth.com. The webcast will be archived and available for replay after the event.
About Guardant Health
Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn, X (Twitter) and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240724630393/en/
Investor Contact:
Zarak Khurshid
investors@guardanthealth.com
Media Contact:
Melissa Marasco
press@guardanthealth.com
+1 650-647-3711
Source: Guardant Health, Inc.
FAQ
When will Guardant Health report its second quarter 2024 financial results?
How can I access the Guardant Health second quarter 2024 financial results conference call?
Will the Guardant Health second quarter 2024 financial results webcast be available for replay?
What is the stock symbol for Guardant Health?
